- Home
- MX vs WHWK Comparison
MX vs WHWK Comparison
Compare MX & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MX
- WHWK
- Stock Information
- Founded
- MX 2003
- WHWK 2007
- Country
- MX South Korea
- WHWK United States
- Employees
- MX N/A
- WHWK N/A
- Industry
- MX Semiconductors
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- MX Technology
- WHWK Health Care
- Exchange
- MX Nasdaq
- WHWK Nasdaq
- Market Cap
- MX 103.8M
- WHWK 90.0M
- IPO Year
- MX N/A
- WHWK N/A
- Fundamental
- Price
- MX $3.17
- WHWK $2.19
- Analyst Decision
- MX Strong Buy
- WHWK
- Analyst Count
- MX 2
- WHWK 0
- Target Price
- MX $5.75
- WHWK N/A
- AVG Volume (30 Days)
- MX 239.8K
- WHWK 133.0K
- Earning Date
- MX 10-29-2025
- WHWK 11-15-2025
- Dividend Yield
- MX N/A
- WHWK N/A
- EPS Growth
- MX N/A
- WHWK N/A
- EPS
- MX N/A
- WHWK N/A
- Revenue
- MX $234,243,000.00
- WHWK $21,596,000.00
- Revenue This Year
- MX N/A
- WHWK N/A
- Revenue Next Year
- MX $7.05
- WHWK N/A
- P/E Ratio
- MX N/A
- WHWK N/A
- Revenue Growth
- MX 16.02
- WHWK N/A
- 52 Week Low
- MX $2.51
- WHWK $1.39
- 52 Week High
- MX $5.16
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- MX 45.53
- WHWK 76.75
- Support Level
- MX $3.17
- WHWK $1.85
- Resistance Level
- MX $3.29
- WHWK $1.97
- Average True Range (ATR)
- MX 0.10
- WHWK 0.10
- MACD
- MX -0.01
- WHWK 0.02
- Stochastic Oscillator
- MX 5.94
- WHWK 77.27
About MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.